NanoViricides
NNVC
#10407
Rank
โ‚ฌ33.59 M
Marketcap
1,32ย โ‚ฌ
Share price
-1.94%
Change (1 day)
-3.99%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -0,39ย โ‚ฌ

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -0,38ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,55ย โ‚ฌ an increase over its 2024 EPS that were of -0,61ย โ‚ฌ.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,39ย โ‚ฌ-29.31%
2025-0,55ย โ‚ฌ-10%
2024-0,61ย โ‚ฌ-5.41%
2023-0,64ย โ‚ฌ5.71%
2022-0,61ย โ‚ฌ-13.58%
2021-0,70ย โ‚ฌ-66.11%
2020-2,07ย โ‚ฌ1.7%
2019-2,04ย โ‚ฌ-10.98%
2018-2,29ย โ‚ฌ-22.35%
2017-2,95ย โ‚ฌ-10.53%
2016-3,29ย โ‚ฌ375%
2015-0,69ย โ‚ฌ-85.19%
2014-4,68ย โ‚ฌ42.11%
2013-3,29ย โ‚ฌ26.67%
2012-2,60ย โ‚ฌ-6.25%
2011-2,77ย โ‚ฌ14.28%
2010-2,43ย โ‚ฌ100%
2009-1,21ย โ‚ฌ-0%
2008-1,21ย โ‚ฌ-33.33%
2007-1,82ย โ‚ฌ-0%
2006-1,82ย โ‚ฌ4445.07%
2005-0,04005ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
6,43ย โ‚ฌ-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,10ย โ‚ฌ-912.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
3,09ย โ‚ฌ-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,37ย โ‚ฌ-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-0,47ย โ‚ฌ 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-1,50ย โ‚ฌ 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA